ID   Ff-XT18s02
SY   Ff-XT 18s02
DR   Wikidata; Q114311426
RX   PubMed=31497180;
RX   PubMed=36395757;
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*07:02; DRB1*01:01 (CiRA).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1E3 ! DRXT18s02
OI   CVCL_C1E4 ! DRXT18s03
OI   CVCL_C1E5 ! DRXT28s04
OI   CVCL_C1E6 ! DRXT28s05
OI   CVCL_C1E7 ! DRXT28s17
OI   CVCL_C1E9 ! Ff-XT18s03
OI   CVCL_C1EA ! Ff-XT28s04
OI   CVCL_C1EB ! Ff-XT28s05
OI   CVCL_C1EC ! Ff-XT28s17
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 02-05-24; Version: 5
RX   PubMed=31497180; DOI=10.1186/s41232-019-0106-0;
RA   Umekage M., Sato Y., Takasu N.;
RT   "Overview: an iPS cell stock at CiRA.";
RL   Inflamm. Regen. 39:17.1-17.5(2019).
RX   PubMed=36395757; DOI=10.1016/j.medj.2022.10.003;
RA   Yoshida S., Kato T.M., Sato Y., Umekage M., Ichisaka T., Tsukahara M.,
RA   Takasu N., Yamanaka S.;
RT   "A clinical-grade HLA haplobank of human induced pluripotent stem
RT   cells matching approximately 40% of the Japanese population.";
RL   Med 4:51-66.e10(2023).